A candid discussion among some of the most experienced, innovative thinkers on the key challenges that must be addressed if the cellular cancer immunotherapy field is to fully realize its undoubted commercial potential.
48:21
Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.